US Broker Ratings

Rhythm Pharmaceuticals, Inc. (RYTM): Investor Outlook Reveals 60% Potential Upside in Biotech Sector

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is drawing significant attention in the biotechnology sector with its promising pipeline aimed at rare neuroendocrine diseases. With a robust market cap of $5.85 billion,..

ADMA Biologics Inc (ADMA) Stock Analysis: Could an 83% Potential Upside Be Within Reach?

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, is capturing the attention of investors with a significant potential upside. With a market capitalization of $2.62 billion,..

BeOne Medicines Ltd. (ONC) Investor Outlook: Exploring a 35.71% Potential Upside in the Oncology Powerhouse

For investors seeking a strategic entry into the biotechnology sector, BeOne Medicines Ltd. (ONC) presents a compelling opportunity with its robust pipeline of oncology treatments and a significant potential upside..

BrightSpring Health Services (BTSG) Stock Analysis: Revenue Growth and Analyst Confidence Signal Promising Potential

BrightSpring Health Services, Inc. (NYSE: BTSG) is making waves in the healthcare sector, specifically in health information services. With a current market capitalization of $9.3 billion, the company is a..

Masimo Corporation (MASI) Stock Analysis: Evaluating the Growth Potential in the Healthcare Sector

Masimo Corporation (MASI), a notable player in the healthcare sector, specializes in medical devices that revolutionize patient monitoring and connectivity solutions. Headquartered in Irvine, California, the company commands a market..

Ascendis Pharma A/S (ASND) Stock Analysis: Unpacking a 29.97% Potential Upside for Investors

Ascendis Pharma A/S (NASDAQ: ASND), a Denmark-based biotechnology firm, is catching the attention of investors with a promising potential upside of nearly 30%. As a leader in developing innovative therapies..

Humana Inc. (HUM)

⚠️ No article content returned.

..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Significant 42% Upside Potential Beckons Investors

Cytokinetics, Incorporated (NASDAQ: CYTK), a pioneering biopharmaceutical company, has been making waves in the biotechnology sector with its innovative approach to addressing debilitating diseases through muscle activators and inhibitors. With..

Atrium Therapeutics, Inc. (RNA)

⚠️ No article content returned.

..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: 59.38% Potential Upside Ignites Investor Interest

iRhythm Holdings, Inc. (NASDAQ: IRTC) stands at the forefront of the digital healthcare sector, focusing on the design and commercialization of cutting-edge medical devices for cardiac monitoring. As the U.S...

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 9.10% Upside Potential

Align Technology, Inc. (NASDAQ: ALGN), a prominent player in the healthcare sector specializing in medical instruments and supplies, has piqued investor interest with its innovative offerings such as Invisalign clear..

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring a Potential 16.52% Upside in Healthcare

Investors with an eye on the healthcare sector may want to take a closer look at The Ensign Group, Inc. (NASDAQ: ENSG), a company that has carved out a robust..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Evaluating a 12.81% Potential Upside in Medical Devices

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a stalwart in the healthcare sector, remains a key player in the medical devices industry. Founded in 1927 and headquartered in Warsaw, Indiana, the..

Avantor, Inc. (AVTR) Stock Analysis: Evaluating the 33.89% Potential Upside

Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector, operates within the medical instruments and supplies industry. The company, with a market capitalization of $5.39 billion, is headquartered..

Genmab A/S (GMAB) Stock Analysis: Unlocking a 40% Upside Potential with Biotech Innovation

Genmab A/S (NASDAQ: GMAB), an influential player in the biotechnology sector, commands attention with its promising portfolio of antibody-based products aimed at combating cancer and other severe diseases. Headquartered in..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring an 8.41% Potential Upside in the Medical Devices Sector

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector, has carved a niche within the medical devices industry. With a market capitalization of $2.96 billion, ITGR stands..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring a 15.59% Potential Upside in Genetic Medicine Innovations

Krystal Biotech, Inc. (NASDAQ: KRYS) is making waves in the biotechnology sector, primarily focusing on developing genetic medicines that address diseases with unmet medical needs. As the company continues to..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a Mixed Bag of Market Signals

Oscar Health, Inc. (NYSE: OSCR), with its innovative approach to healthcare technology, stands at an intriguing juncture for investors. As the company continues to carve a niche within the competitive..

RadNet, Inc. (RDNT) Stock Analysis: Exploring a 56.82% Upside Potential in Healthcare Imaging

RadNet, Inc. (NASDAQ: RDNT) is carving out a significant niche within the healthcare sector, specifically in diagnostics and research. With its headquarters in Los Angeles, California, RadNet provides essential outpatient..

Insmed Incorporated (INSM) Stock Analysis: Unveiling a Potential 57% Upside with Cutting-Edge Biotech Innovations

Investors with a keen eye on the biotechnology sector may find Insmed Incorporated (NASDAQ: INSM) an intriguing proposition. Despite a recent dip in share price to $135.17, representing a minor..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds